REFERENCES
  1. Sallet JA, Marchesini JB, Paiva DS, Komoto K, Pizani CE, Ribeiro ML, Miguel P, Ferraz AM, Sallet PC. Brazilian multicenter study of intragastric balloon. Obes Surg. 2004;14:991–8. [PMID:15329191]
  2. Genco A, Bruni T, Doldi SB, Forestieri P, Marino M, Busetto L, Giardiello C, Angrisani L, Pecchioli L, Stornelli P, Puglisi F, Alkilani M, Nigri A, Di Lorenzo N,Furbetta F, Cascardo A, Cipriano M, Lorenzo M, Basso N. BioEnterics Intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4. [PMID:16197790]
  3. Forlano R, Ippolito AM, Iacobellis A, Merla A, Valvano MR, Niro G, Annese V, Andriulli A. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc 2010;71:927-33.[PMID:19863955 / DOI:10.1016/j.gie.2009.06.036.]
  4. Wahlen CH, Bastens B, Herve J, Malmendier C, Dallemagne B, Jehaes C, Markiewicz S, Monami B, Weerts J. The Bio Enterics Intragastric Balloon (BIB): how to use it. Obes Surg 2001; 11: 524-7. [PMID:11501368]
  5. Imaz I, Martínez-Cervell C, García-Alvarez EE, Sendra-Gutiérrez JM, González-Enríquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6. [PMID:18459025 / doi: 10.1007/s11695-007-9331-8.]
  6. Machytka E, Brooks J, Buzga M and Mason J. One year adjustable intragastric balloon: safety and efficacy of the Spatz3 adjustable balloons [v1; ref status: approved with reservations 2, http://f1000r.es/471] F1000Research 2014, 3:203 (doi:10.12688/f1000research.5099.1)
  7. Schapiro M, Benjamin S, Blackburn G, Frank B, Heber D, Kozarek R, Randall S, Stern W.Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19-21, 1987. Gastrointest Endosc 1987; 33: 323-7. [PMID:3653653]
  8. Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen LE, Gostout C, Lopez-Nava G, Shikora S, Brooks J. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011, 21(10):1499-507. [PMID:21553304 / doi: 10.1007/s11695-011-0424-z.]
  9. Genco A, Dellepiane D, Baglio G, Cappelletti F, Frangella F, Maselli R, Dante MC, Camoirano R, Lorenzo M, Basso N. Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy. Obes Surg. 2013 Jul;23(7):953-8. [PMID:23526067 / doi: 10.1007/s11695-013-0891-5.]
  10. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2014; 63:2985-3023. [PMID:24239920 / doi: 10.1016/j.jacc.2013.11.004.]
  11. Herve J, Wahlen CH, Schaeken A, Dallemagne B, Dewandre JM, Markiewicz S, Monami B, Weerts J, Jehaes C. What Becomes of Patients One Year after the Intragastric Balloon has been Removed? Obes Surg 2005, 15, 864-870 [PMID:15978160]
  12. Lopez-Nava G, Rubio MA, Prados S, Pastor G, Cruz MR, Companioni E, Lopez A. BioEnterics® Intragastric Balloon (BIB®). Single Ambulatory Center Spanish Experience with 714 Consecutive Patients Treated with One or Two Consecutive Balloons. Obes Surg 2011 21:5–9. [PMID:20306153 / doi: 10.1007/s11695-010-0093-3.]
  13. Stimac D, Majanović SK, Turk T, Kezele B, Licul V, Orlić ZC. Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg 2011;21:551-5. [PMID:21170685 / doi: 10.1007/s11695-010-0310-0.]
  14. Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg. 2014; 24(5):813-9 [PMID:24442419 / doi: 10.1007/s11695-014-1176-3.]
  15. Mion F, Napoléon B, Roman S, Malvoisin E, Trepo F, Pujol B, Lefort C, Bory RM. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in nonmorbid obese patients. Obes. Surg. 2005; 15: 510–6. [PMID:15946431]
  16. Mui WL, Ng EK, Tsung BY, Lam CH, Yung MY. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20(8):1128–32.[ PMID:19015930 / doi: 10.1007/s11695-008-9766-6.]
  17. Al Kahtani K, Khan MQ, Helmy A, Al Ashgar H, Rezeig M, Al Quaiz M, Kagevi I, Al Sofayan M, Al Fadda M. Bio-enteric intragastric balloon in obese patients: a retrospective analysis of King Faisal Specialist Hospital experience. Obes Surg.2010;20(9):1219–26.[PMID:18752030 / doi: 10.1007/s11695-008-9654-0.]
  18. Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 Intragastric Balloons: What Happens 5 Years Thereafter. Obes Surg 2012; 22:896-903.[ PMID:22287051 / doi: 10.1007/s11695-012-0607-2.]
  19. Herve J, Wahlen CH, Schaeken A, Dallemagne B, Dewandre JM, Markiewicz S, Monami B, Weerts J, Jehaes C. What Becomes of Patients One Year after the Intragastric Balloon has been Removed? Obes Surg 2005, 15, 864-870. [PMID:15978160]
  20. Dastis NS, François E, Deviere J, Hittelet A, Ilah Mehdi A, Barea M, Dumonceau JM. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoskopie Heute 2009;22:151-8. [PMID:19588283 / doi: 10.1055/s-0029-1214826]
  21. Papademetriou M, Popov V. Intragastric Balloons in Clinical Practice. Gastrointest Endosc Clin N Am. 2017 Apr;27(2):245-256. Doi: 10.1016/j.giec.2016.12.006.
  22. Laing P, Pham T, Taylor LJ, Fang J. Filling the Void: A Review of Intragastric Balloons for Obesity. Dig Dis Sci. 2017 Jun;62(6):1399-1408. Doi: 10.1007/s10620-017-4566-2. Epub 2017 Apr 18.
  23. Sampath K, Dinani AM, Rothstein RI. Endoscopic Devices for Obesity. Curr Obes Rep. 2016 Jun;5(2):251-61. Doi: 10.1007/s13679-016-0217-8.
  24. Seung Han Kim, Hoon Jai Chun, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, and Yoon Tae Jeen. Current status of intragastric balloon for obesity treatment. World J Gastroenterol. 2016 Jun 28; 22(24): 5495–5504. Published online 2016 Jun 28. Doi: 10.3748/wjg.v22.i24.5495.
  25. Daniel F, Abou Fadel C, Houmani Z, Salti N. Spatz 3 Adjustable Intragastric Balloon: Long-Term Safety Concerns. Obes Surg. 2016 Jan;26(1):159-60. Doi: 10.1007/s11695-015-1897-y.
  26. Yap Kannan R, Nutt MR. Are intra-gastric adjustable balloon system safe? A case series. Int J Surg Case Rep. 2013;4(10):936-8. Doi: 10.1016/j.ijscr.2013.07.025. Epub 2013 Aug 13.
  27. Russo T, Aprea G, Formisano C, Ruggiero S, Quarto G, Serra R, Massa G, Sivero L.BioEnterics Intragastric Balloon (BIB) versus Spatz Adjustable Balloon System (ABS): Our experience in the elderly. Int J Surg. 2017 Feb;38:138-140. Doi: 10.1016/j.ijsu.2016.06.013. Epub 2016 Jun 21.
Table 1. Complications of Spatz3® Balloons.